Clinical trials
Terminated Phase 2 Smoldering Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Barbara Ann Karmanos Cancer Institute | 1 |
| BioInvent International AB | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Lene Meldgaard Knudsen | 1 |
| Marshall University | 1 |
| Mayo Clinic | 1 |
| NYU Langone Health | 1 |
| National Cancer Institute (NCI) | 1 |
| University of Utah | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Smoldering Multiple Myeloma | 9 |
| Neoplasms, Plasma Cell | 6 |
| Multiple Myeloma | 5 |
| Monoclonal Gammopathy of Undetermined Significance | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Neoplasms | 1 |
| Precancerous Conditions | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.